Back to Search Start Over

In vitro three-dimensional cell cultures for bone sarcomas

Authors :
Aurélie Loussouarn
Matisse Goumard
Dominique Heymann
Laurent Griscom
Axelle Renodon-Cornière
Javier Muñoz-Garcia
Camille Jubelin
Marie-Françoise Heymann
Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO)
UNICANCER
Apoptosis and Tumor Progression (CRCINA-ÉQUIPE 9)
Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA)
Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)
Atlantic Bone Screen [Saint-Herblain] (ABS)
Biosit : biologie, santé, innovation technologique (SFR UMS CNRS 3480 - INSERM 018)
Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )
Department of Oncology and Metabolism [Sheffield, UK]
The University of Sheffield [Sheffield, U.K.]
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE)
Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE)
Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)
Université de Rennes 1 (UR1)
Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )
Heymann, Dominique
Source :
Journal of Bone Oncology, Journal of Bone Oncology, 2021, 30, pp.100379. ⟨10.1016/j.jbo.2021.100379⟩, Journal of Bone Oncology, Amsterdam : Elsevier, c2012-, 2021, 30, pp.100379. ⟨10.1016/j.jbo.2021.100379⟩, Journal of Bone Oncology, Vol 30, Iss, Pp 100379-(2021)
Publication Year :
2021
Publisher :
Elsevier BV, 2021.

Abstract

Highlights • 3D cell cultures present similar drugs resistance features than in vivo tumours. • Unlike 2D cell cultures, 3D culture approaches mimic better the tumour microenvironment. • Collagen scaffolds result in a better osteosarcoma 3D proliferation than soft hydrogels. • Osteosarcoma 3D models constitute an appealing approach for bone mineralisation studies. • Combination of microfluidic/bioprinting technology with bone 3D cultures as ideal tools to study bone sarcomas.<br />Bone sarcomas are rare tumour entities that arise from the mesenchyme most of which are highly heterogeneous at the cellular, genetic and epigenetic levels. The three main types are osteosarcoma, Ewing sarcoma, and chondrosarcoma. These oncological entities are characterised by high morbidity and mortality and an absence of significant therapeutic improvement in the last four decades. In the field of oncology, in vitro cultures of cancer cells have been extensively used for drug screening unfortunately with limited success. Indeed, despite the massive knowledge acquired from conventional 2D culture methods, scientific community has been challenged by the loss of efficacy of drugs when moved to clinical trials. The recent explosion of new 3D culture methods is paving the way to more relevant in vitro models mimicking the in vivo tumour environment (e.g. bone structure) with biological responses close to the in vivo context. The present review gives a brief overview of the latest advances of the 3D culture methods used for studying primary bone sarcomas.

Subjects

Subjects :
3D culture
[SDV.MHEP.AHA] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]
Multicellular tumour spheroid
Mesenchyme
Microfluidics
Chondrosarcoma
[SDV.CAN]Life Sciences [q-bio]/Cancer
Context (language use)
Review Article
Diseases of the musculoskeletal system
[SDV.BC.IC] Life Sciences [q-bio]/Cellular Biology/Cell Behavior [q-bio.CB]
Bone Sarcoma
03 medical and health sciences
[SDV.MHEP.PED] Life Sciences [q-bio]/Human health and pathology/Pediatrics
0302 clinical medicine
[SDV.CAN] Life Sciences [q-bio]/Cancer
In vivo
[SDV.BC.IC]Life Sciences [q-bio]/Cellular Biology/Cell Behavior [q-bio.CB]
[SDV.MHEP.AHA]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]
medicine
RC254-282
030304 developmental biology
[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism
[SDV.MHEP.RSOA] Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system
Osteosarcoma
[SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics
0303 health sciences
business.industry
Bioprinting
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Extracellular matrix
[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism
medicine.disease
3. Good health
Primary bone
medicine.anatomical_structure
RC925-935
[SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system
Oncology
030220 oncology & carcinogenesis
Cancer research
Sarcoma
business
Ewing sarcoma
Scaffold-based 3D culture

Details

ISSN :
22121374
Volume :
30
Database :
OpenAIRE
Journal :
Journal of Bone Oncology
Accession number :
edsair.doi.dedup.....3190aad2f97693723be7b8dd70482b38